Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Julia Maria Adler

Charité - Universitätsmedizin Berlin

Germany

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Virology

90%

Immunology

50%

Sars-cov-2

80%

Avian Influenza

30%

Covid-19

30%

Molecular Epidemiology

20%

Antiviral Therapy

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles15

A single mutation may contribute to accelerated evolution of SARS-CoV-2 toward Omicron

Article Link

Year:

2025

Improving the Antigenicity of SARS-CoV-2 Vaccine Genes by Merging Mutations from Different Variants of Concern

Article Link

Year:

2024

Mucus‐Inspired Self‐Healing Hydrogels: A Protective Barrier for Cells against Viral Infection

Article Link

Year:

2024

An intranasal live-attenuated SARS-CoV-2 vaccine limits virus transmission.

Article Link

Year:

2024

Sulfated Cellulose Nanofiber Hydrogel with Mucus-Like Activities for Virus Inhibition.

Article Link

Year:

2024

Mucin‐Inspired Single‐Chain Polymer (MIP) Fibers as Potent SARS‐CoV‐2 Inhibitors

Article Link

Year:

2023

Mucin‐inspirierte Einzelstrang‐Polymerfasern (MIP) als wirksame SARS‐CoV‐2‐Inhibitoren

Article Link

Year:

2023

Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters

Article Link

Year:

2023

Functionalized Fullerene for Inhibition of SARS‐CoV‐2 Variants

Article Link

Year:

2023

The FDA-Approved Drug Cobicistat Synergizes with Remdesivir to Inhibit SARS-CoV-2 Replication in Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters

Article Link

Year:

2022

Prevalence of anti‐severe acute respiratory syndrome coronavirus 2 antibodies in cats in Germany and other European countries in the early phase of the coronavirus disease‐19 pandemic

Article Link

Year:

2022

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

Article Link

Year:

2022

Key benefits of dexamethasone and antibody treatment in COVID-19 hamster models revealed by single-cell transcriptomics

Article Link

Year:

2022

Live attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta)

Article Link

Year:

2021

Deciphering the Role of Humoral and Cellular Immune Responses in Different COVID-19 Vaccines—A Comparison of Vaccine Candidate Genes in Roborovski Dwarf Hamsters

Article Link

Year:

2021

Collaborators21

Volker Thiel

Professor and Chair Virology

University of Bern

SWITZERLAND

Anne Voss

Freie Universität Berlin

GERMANY

Geraldine Nouailles

GERMANY

Morris Baumgardt

GERMANY

Aileen Ebenig

Paul-Ehrlich-Institut

GERMANY

Nikolaus Osterrieder

Professor

Freie Universität Berlin

GERMANY

Vibor Laketa

Head of Infectious Diseases Imaging Platform (IDIP)

Ruprecht Karls Universität Heidelberg

GERMANY

Michael Muehlebach

Section Head

Paul-Ehrlich-Institut

GERMANY

Jalid Sehouli

GERMANY

Oliver T Fackler

GERMANY

Carol D. Weiss

Medical Officer, Principal Investigator, Chief, Lab of Immunoregulation

US Food and Drug Administration

UNITED STATES

Christine Goffinet

Associate Professor

Charité - Universitätsmedizin Berlin

GERMANY

Iart Luca Shytaj

Lecturer

University of Bristol

UNITED KINGDOM

Jakob Kreye

GERMANY

Liv Zimmermann

Heidelberg University

GERMANY

Mirko Cortese

Associate Professor

Università degli studi della Campania Luigi Vanvitelli Dipartimento di Scienze e Tecnologie Ambientali Biologiche e Farm

ITALY

Petr Chlanda

GERMANY

Jakob Trimpert

Freie Universität Berlin

GERMANY

Ievgen S. Donskyi

GERMANY

Kai Ludwig

Freie Universität Berlin

GERMANY

Markus Landthaler

Humboldt-Universität zu Berlin

GERMANY

How do I reach out?

Meet Kite AI